Learn More
Medchemexpress LLC DX600 (TFA) | 99.2% | 3074.33 (free acid) | 5 MG

Supplier: Medchemexpress LLC HYP2222A5MG
DX600 TFA is a selective ACE2 specific inhibitor with a KD of 1.3 nM, and it does not cross-react with ACE. This compound exacerbates diabetes-induced cardiovascular dysfunction and increases cardiac and renal NOX activity. It is intended for research use only.
- Inhibits rhACE2 activity.
- Decreases NR 8383 cell growth and increases TNF-a and IL-6 content.
- Exacerbates diabetes-induced cardiovascular dysfunction.
- Increases thrombus weight in a thrombosis model.
- Increases cardiac and renal NOX activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.